CSII Share Price

Open 32.58 Change Price %
High 32.91 1 Day 0.31 0.96
Low 32.14 1 Week 0.04 0.12
Close 32.72 1 Month 1.96 6.37
Volume 134236 1 Year 13.35 68.92
52 Week High 33.11
52 Week Low 18.82
CSII Important Levels
Resistance 2 33.43
Resistance 1 33.14
Pivot 32.59
Support 1 32.30
Support 2 32.01
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
ZOOM 0.10 400.00%
AMCF 0.03 200.00%
SCHS 0.05 66.67%
LOCM 0.09 50.00%
HAUP 0.10 42.86%
QKLS 0.14 27.27%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
GLCH 1.62 23.66%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Cardiovascular Systems, Inc. (NASDAQ: CSII)

CSII Technical Analysis 5
As on 25th Jul 2017 CSII Share Price closed @ 32.72 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 27.15 & Strong Buy for SHORT-TERM with Stoploss of 31.52 we also expect STOCK to react on Following IMPORTANT LEVELS.
CSII Target for July
1st Target up-side 33.85
2nd Target up-side 34.98
3rd Target up-side 36.12
1st Target down-side 30.61
2nd Target down-side 29.48
3rd Target down-side 28.34
CSII Other Details
Segment EQ
Market Capital 249162480.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.csi360.com
CSII Address
CSII
651 Campus Drive
St. Paul, MN 55112-3495
United States
Phone: 651-259-1600
Fax: 612-677-3355
CSII Latest News
Interactive Technical Analysis Chart Cardiovascular Systems, Inc. ( CSII NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cardiovascular Systems, Inc.
CSII Business Profile
Cardiovascular Systems, Inc. (CSI) is a medical device company. CSI is focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Interventional endovascular treatment of peripheral artery disease (PAD) is the Company�s initial area of focus. The Company�s primary products include the Diamondback 360 PAD System (Diamondback 360), Diamondback Predator 360 PAD System (Predator 360) and Stealth 360 PAD System (Stealth 360). Diamondback 360, the Predator 360 and the Stealth 360 collectively are referred to as PAD Systems. As of June 30, 2011, the PAD Systems had been utilized in more than 50,000 procedures. It uses internally manufactured and externally sourced to manufacture the PAD Systems. In addition to the PAD Systems, CSI is expanding its product portfolio through internal product development and establishment of business relationships with other medical device companies.